Results 241 to 250 of about 512,677 (302)

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update [PDF]

, 2018
et al,, Picus, Joel
core   +1 more source

Hidden in Plain Sight: Metastatic Renal Cell Carcinoma Masquerading as Multinodular Thyroid Disease. [PDF]

Cureus
Toal CA, Aronova A, Zenali M.
europepmc   +1 more source

The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma [PDF]

, 2018
et al,, Hsieh, James J
core   +1 more source

Recurrent Macular Edema Associated With Belzutifan Therapy for Metastatic Renal Cell Carcinoma. [PDF]

J Vitreoretin Dis
Chung ME, Wai KM.
europepmc   +1 more source

A case report of cerebral vasculitis induced by ipilimumab with nivolumab in a patient with metastatic renal cell carcinoma. [PDF]

Front Immunol
Palacka P, Málek T, Makovník M, Felediová R, Rychlý B, Kolníková G.   +5 more
europepmc   +1 more source

Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma.

JAMA Netw Open
Zarba M, Saad E, Semaan K, El Zarif T, Ferrier E, Wells C, El Hajj Chehade R, Basappa NS, Ebrahimi H, Huseni M, Banchereau R, McKay RR, Wood L, Beuselinck B, Suárez C, Takemura K, Lalani AA, Li H, Spain LA, Templeton AJ, Powles TB, Bjarnason GA, de Velasco G, Choueiri TK, Heng DYC.   +24 more
europepmc   +1 more source